Sodium Bicarbonate — products, DINs, and Canadian availability

This page lists Health Canada–registered pharmaceutical products whose active ingredient list includes Sodium Bicarbonate. We track 120 distinct Drug Identification Numbers (DINs) for this molecule, of which 23 are currently in marketed status. Across those registrations there are 60 manufacturers or marketing authorization holders, 14 dosage forms, and 86 distinct strength presentations.

Procurement teams normally arrive here for one of three reasons: a specific brand is unavailable and an equivalent registration is needed; a clinical protocol requires a comparator containing Sodium Bicarbonate in a defined strength; or a pharmacy needs to know which manufacturers still hold an active Canadian registration before committing to a substitution. The table below answers the first question directly. For the second and third, Nexara Health can confirm live availability, remaining shelf life, and landed cost from Canadian stock or from any of more than 40 regulated international source markets.

Registration status is not the same as availability. A product can hold marketed status in the Drug Product Database and still be on allocation, discontinued by the holder, or unavailable in the pack size a hospital needs. Where a Sodium Bicarbonate product is in shortage, our Canadian drug shortage tracker carries the reported status, the reason where the manufacturer has published one, and the marketed alternatives sharing the same active ingredient.

Dosage forms and strengths recorded for Sodium Bicarbonate

Dosage forms: Powder For Solution, Tablet (Effervescent), Liquid, Powder, Powder (Effervescent), Kit; Tablet (Delayed-Release); Powder For Solution, Solution, Powder For Solution; Kit, Granules, Kit; Solution, Suppository, Tablet. Strengths: 650 G, 325 MG, 7.14 MG, 6600 UNIT, 266 MG, 72 MG, 3.6 MG, 100 %, 460 MG, 223 G, 7.54 %, 5 MG, 900 G, 81.25 G.

Manufacturers and marketing authorization holders

BAXTER CORPORATION, MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION, BAYER INC, BAYER INC CONSUMER CARE, AMO CANADA COMPANY, VETOQUINOL N A INC, LES PRODUITS GERBEX INC., DANNORTH LABORATORIES INC., BLOCK DRUG COMPANY (CANADA) LTD., G.T. FULFORD PHARMACEUTICALS, REGAL PHARMS, DIVISION OF BRADCAN CORPORATION, TYCO HEALTHCARE, RENAL SYSTEMS, DIVISION OF MINNTECH CORP., DOMINION VETERINARY LABORATORIES LTD., PENDOPHARM DIVISION OF PHARMASCIENCE INC, FRESENIUS MEDICAL CARE CANADA INC, BICARBOLYTE CORPORATION, CHIEF MEDICAL SUPPLIES LTD, VANTIVE ULC, WESTERN DIALYSIS SUPPLIES LTD., and others.

Registered products containing Sodium Bicarbonate

Sourcing Sodium Bicarbonate through a licensed wholesaler

Nexara Health imports and distributes under Health Canada Drug Establishment Licence #3-002896. For Sodium Bicarbonate we can quote Canadian-marketed presentations, equivalent registrations from the EU, UK, US, Switzerland, Australia, and Japan where the Canadian presentation is unavailable, and comparator-grade supply with Certificate of Analysis, batch and expiry records, and full chain of custody for clinical trial use. Cold-chain presentations ship under GDP conditions with continuous temperature monitoring.

Related pages

• Browse all active ingredients
• Canadian drug shortage tracker
• Alternatives to Sodium Bicarbonate
• Comparator sourcing for clinical trials